Targeted therapy for advanced anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Targeted Therapy for Advanced Anaplastic Lymphoma Kinase (ALK)‐rearranged Non‐small Cell Lung Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439008/1/. Accessed 27 April 2024.
Targeted therapy for advanced anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439008/1/. Accessed April 27, 2024.
Targeted therapy for advanced anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439008/1/
Targeted Therapy for Advanced Anaplastic Lymphoma Kinase (ALK)‐rearranged Non‐small Cell Lung Cancer [Internet]. In: Cochrane Abstracts. [cited 2024 April 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439008/1/.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Targeted therapy for advanced anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer
ID - 439008
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439008/1/
DB - Evidence Central
DP - Unbound Medicine
ER -